| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/30/2004 | CN1509282A 4-(phenyl-piperdin-4-ylidene-methyl)benzamide derivatives and theive use for treating pain, anxiety or gastrointestinal disorders |
| 06/30/2004 | CN1509281A Benzimidazol derivatives modulate che mokine receptors |
| 06/30/2004 | CN1509280A 手性化合物 Chiral compounds |
| 06/30/2004 | CN1509279A Process for production of citalopram |
| 06/30/2004 | CN1509278A N-phenyl-arylsulfonamide compound, drug comprising the compound as active ingredient, intermediate for the compound |
| 06/30/2004 | CN1509277A Process for preparing paclitaxel |
| 06/30/2004 | CN1509276A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509275A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509274A Metallo proteinase inhibitors |
| 06/30/2004 | CN1509273A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509272A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509271A 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for treatment of pain anxiety or gastrointestinal disorders |
| 06/30/2004 | CN1509270A Indolinons, substituted in position 6, and their preparation and use as kinase inhibitors |
| 06/30/2004 | CN1509269A 磺酰胺衍生物 Sulfonamide derivatives |
| 06/30/2004 | CN1509267A Thyroid hormone receptor atagonists for treating cardiac and metabolic disorders II |
| 06/30/2004 | CN1509196A 4(2-butylamino)-2,7-dimethyl-8-(2-methyl(-6-methoxyp-3-yl)pyrazolo-[1,5-A]-1,3,5-triazine as corticotropin releasing factor receptor |
| 06/30/2004 | CN1509187A Cytotoxic CD44 antibody immunoconjugates |
| 06/30/2004 | CN1509186A Composition containing epigallocatechin gallate |
| 06/30/2004 | CN1509185A Medicinal composition |
| 06/30/2004 | CN1509184A Antipruritscs |
| 06/30/2004 | CN1509183A Use of proteasome inhibitors to treat dry eye disorders |
| 06/30/2004 | CN1509182A Use of extracts and preparations from iris plants and tectorigenin as organ selective medicament for treating urethra disease |
| 06/30/2004 | CN1509180A Method for treating syndrome X with aliphatic polyamines |
| 06/30/2004 | CN1509179A External skin composition |
| 06/30/2004 | CN1509178A Pharmaceutical composition comprising lysophosphatidic acid |
| 06/30/2004 | CN1509177A Method for treating dry eye disorders |
| 06/30/2004 | CN1509176A Cathartic composition |
| 06/30/2004 | CN1509175A Novel Use |
| 06/30/2004 | CN1509174A Tartrate salt of 5,8,14-triazatetracyclo [10,3,1,02,11.04,9]-hexzdeca-2(11),3,5,7,9-pentaene |
| 06/30/2004 | CN1509173A Carboxylic and substituted oxazole derivatives for use as PPAR-& and PPAR-r activators in the treatment of diabetes |
| 06/30/2004 | CN1509172A Pirenzepine ophthalmic gel |
| 06/30/2004 | CN1509171A Use of pyrazoline derivatives in preparation of medicament for prevention and/or treatment of proliferative cell diseases |
| 06/30/2004 | CN1509170A Method for inhibiting adhesion formation |
| 06/30/2004 | CN1509169A Use of enantiomeric pure escitalopram |
| 06/30/2004 | CN1509168A Novel treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG |
| 06/30/2004 | CN1509165A Liquid pharmaceutical composition |
| 06/30/2004 | CN1509164A System for delivering consmetics and pharmaceuticals. |
| 06/30/2004 | CN1509162A Cosmetics |
| 06/30/2004 | CN1509144A Prebiotic and probiotic compositions and method for use in gut-based therapies |
| 06/30/2004 | CN1508542A Ginkgo leaf composition, and preparing method and use thereof |
| 06/30/2004 | CN1508251A Malignant malarial parasite msra-3 gene, protein product and use thereof |
| 06/30/2004 | CN1508250A Malignant malarial parasite msra-2 gene, protein product and use thereof |
| 06/30/2004 | CN1508249A Maiignant malarial parasite msra-1 gene, protein product and use thereof |
| 06/30/2004 | CN1508176A Elemene nydroxy propyl-beta-cyclodextrin clathrate and preparation and preparing method thereof |
| 06/30/2004 | CN1508147A Method for preparing low-polarity ginseng saponin and its aglycone by catalytic pyrolysis |
| 06/30/2004 | CN1508146A Anti-tumour ginseng saponin |
| 06/30/2004 | CN1508145A Anti-tumour ginseng saponin aglycone derivatives |
| 06/30/2004 | CN1508137A 2-phenyl-substituted imidazo-triazone used as phosphodiesterase inhibitor |
| 06/30/2004 | CN1508136A Tetrahydropyrido compound |
| 06/30/2004 | CN1508134A Anti-cance active substance of cyathocline purpurea and separating and purifying method thereof |
| 06/30/2004 | CN1508133A Red-rooted salvia root anti-peptic ulcer effective site and preparing process thereof |
| 06/30/2004 | CN1508131A Ferrous orotic acid, and preparing method and use thereof |
| 06/30/2004 | CN1507922A Substance for eliminating super-antigen or its toxcity |
| 06/30/2004 | CN1507918A Transdermal promotor glycerin triacetate |
| 06/30/2004 | CN1507917A Medicine containing nitric oxide synthase inhibitor for treating diabetes |
| 06/30/2004 | CN1507897A Medicament containing extract from herb of Asiatic Pennywort for treating and preventing proliferation of mammary gland |
| 06/30/2004 | CN1507875A 肿瘤基因开关药物 Tumor gene switch drugs |
| 06/30/2004 | CN1507874A Tumour gene switch medicine |
| 06/30/2004 | CN1507873A 肿瘤基因开关药物 Tumor gene switch drugs |
| 06/30/2004 | CN1507872A Use of P-phenylaldehyde-O-beta-D-allopyranoside for treating depression |
| 06/30/2004 | CN1507871A Use of phytanic acid for treating diabetes |
| 06/30/2004 | CN1507870A Medicinal composition for antipyretic, analgesic, anti-inflammatory and anti platelet aggregation |
| 06/30/2004 | CN1507869A Combined preparation containing morpholine anthracyclines and anticancer agent |
| 06/30/2004 | CN1507868A Desloratadine dry-mixed suspensoid and preparing method thereof |
| 06/30/2004 | CN1507867A Use of alkaloid compounds in preparing medicine |
| 06/30/2004 | CN1507866A Bulley aconitne transdermal paster |
| 06/30/2004 | CN1507865A Diabetes medicine containing tri pyridine chromium formate |
| 06/30/2004 | CN1507864A Endermatic feeding preparation of anti parastic medicine containing benzimidazole |
| 06/30/2004 | CN1507863A Use of aza cyclopentane dione derivative for treating diabetes |
| 06/30/2004 | CN1507862A Complex acetaminophen vitamin C dispersion tablet and preparing method thereof |
| 06/30/2004 | CN1507861A Trimebutine maleate tablet and preparing method thereof |
| 06/30/2004 | CN1507860A Complex prescription preparation of local application for promoting chronic wound healing |
| 06/30/2004 | CN1507859A Pravastatin preparation formula |
| 06/30/2004 | CN1507858A Flrorinated chloromycetin containing liquid preparation for animal |
| 06/30/2004 | CN1507857A Elemene fatty emulsion injection and preparing method thereof |
| 06/30/2004 | CN1507855A Diphenyl acetic acid plaster for anti-inflammatory and analgesic |
| 06/30/2004 | CN1507854A Amphotericin B Liposome and preparing method thereof |
| 06/30/2004 | CN1507789A Oil containing unstaturated fatty acid |
| 06/30/2004 | CN1155706C Method for treating amyotrophic lateral sclerosis |
| 06/30/2004 | CN1155697C Lactobacillus bifidus growth promoting composition and use thereof |
| 06/30/2004 | CN1155648C Silicone gel containing salicylic acid |
| 06/30/2004 | CN1155620C Thioether conjugates |
| 06/30/2004 | CN1155608C Propargyl phenyl ether A2A receptor agonists |
| 06/30/2004 | CN1155603C Process for producing 3-cephem compounds |
| 06/30/2004 | CN1155602C Thineopyranecarboxyamide derivatives |
| 06/30/2004 | CN1155601C Dioxacyclopentedien-6-(5aH)-one compound, its preparation process and medicinal composition |
| 06/30/2004 | CN1155600C 2,3-diaryl-pyrazolo[1,5-B] pyridazines derivatives, their prepn. and use as cyclooxygenase 2(cox-2) inhibitors |
| 06/30/2004 | CN1155599C Tricyclic triazolobenzazepine derivatives, process for producing same, and antiallergic agent |
| 06/30/2004 | CN1155598C Tetrahydropyridoethers |
| 06/30/2004 | CN1155597C Benzodioxan, benzofuran or benzopyranl derivatives having fundic relaxation properties |
| 06/30/2004 | CN1155596C New phenylpiperazines |
| 06/30/2004 | CN1155595C Substituted pyrroles as antiproliferative agents for treatment of cancer |
| 06/30/2004 | CN1155594C Polymorphic salt as medicine for migraine |
| 06/30/2004 | CN1155592C Process for preparing total jujuboflavone with calmative and hypnosis action |
| 06/30/2004 | CN1155589C Compounds and methods for modulation of estroglen receptors |
| 06/30/2004 | CN1155585C 3,5-substituted oxazolidinone derivative and its preparing process and application |
| 06/30/2004 | CN1155574C Ether muscarinic antagonists |
| 06/30/2004 | CN1155571C Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith |
| 06/30/2004 | CN1155570C Novel cyano-indole serotonin reextracted inhibitor compound, its preparation process and medicinal compositions having same |
| 06/30/2004 | CN1155569C Indolin derivs. as sun protection agents |